These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8868355)

  • 1. Gastric bacterial overgrowth accompanies profound acid suppression.
    Patel TA; Abraham P; Ashar VJ; Bhatia SJ; Anklesaria PS
    Indian J Gastroenterol; 1995 Oct; 14(4):134-6. PubMed ID: 8868355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study.
    Thorens J; Froehlich F; Schwizer W; Saraga E; Bille J; Gyr K; Duroux P; Nicolet M; Pignatelli B; Blum AL; Gonvers JJ; Fried M
    Gut; 1996 Jul; 39(1):54-9. PubMed ID: 8881809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids.
    Theisen J; Nehra D; Citron D; Johansson J; Hagen JA; Crookes PF; DeMeester SR; Bremner CG; DeMeester TR; Peters JH
    J Gastrointest Surg; 2000; 4(1):50-4. PubMed ID: 10631362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omeprazole induces altered bile acid metabolism.
    Shindo K; Machida M; Fukumura M; Koide K; Yamazaki R
    Gut; 1998 Feb; 42(2):266-71. PubMed ID: 9536953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
    Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
    Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprozole therapy in pediatric patients after liver and intestinal transplantation.
    Kaufman SS; Lyden ER; Brown CR; Davis CK; Andersen DA; Olsen KM; Bergman KL; Horslen SP; Sudan DL; Fox IJ; Shaw BW; Langnas AN
    J Pediatr Gastroenterol Nutr; 2002 Feb; 34(2):194-8. PubMed ID: 11840039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and significance of gastric colonization during acid-inhibitory therapy.
    Williams C
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):511-21. PubMed ID: 11403543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome.
    Hirschowitz BI; Mohnen J; Shaw S
    Aliment Pharmacol Ther; 1996 Aug; 10(4):507-22. PubMed ID: 8853754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pirenzepine on omeprazole-induced hypergastrinemia and acid suppression in peptic ulcer patients.
    Tari A; Hamada M; Kamiyasu T; Fukino Y; Sumii M; Haruma K; Sumii K; Inoue M; Kajiyama G
    J Gastroenterol; 1996 Apr; 31(2):167-70. PubMed ID: 8680534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa.
    Sanduleanu S; Jonkers D; De Bruine A; Hameeteman W; Stockbrügger RW
    Aliment Pharmacol Ther; 2001 Mar; 15(3):379-88. PubMed ID: 11207513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.
    Thomson AB; Keelan M; Lastiwka R; Appelman-Eszczuk S; Zuk L; Drozdowski L; Prentice A; Sinclair P
    Dig Dis Sci; 2003 Oct; 48(10):2045-56. PubMed ID: 14627354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked increase in gastric acid secretory capacity after omeprazole treatment.
    Waldum HL; Arnestad JS; Brenna E; Eide I; Syversen U; Sandvik AK
    Gut; 1996 Nov; 39(5):649-53. PubMed ID: 9026477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure.
    Ours TM; Fackler WK; Richter JE; Vaezi MF
    Am J Gastroenterol; 2003 Mar; 98(3):545-50. PubMed ID: 12650785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group.
    Bytzer P; Aalykke C; Rune S; Weywadt L; Gjørup T; Eriksen J; Bonnevie O; Bekker C; Kromann-Andersen H; Kjaergaard J; Rask-Madsen J; Vilien M; Hansen J; Justesen T; Vyberg M; Teglbjaerg PS
    Scand J Gastroenterol; 2000 Oct; 35(10):1023-32. PubMed ID: 11099054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of GastroGard and three compounded oral omeprazole preparations on 24 h intragastric pH in gastrically cannulated mature horses.
    Merritt AM; Sanchez LC; Burrow JA; Church M; Ludzia S
    Equine Vet J; 2003 Nov; 35(7):691-5. PubMed ID: 14649361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole is more effective than a histamine H2-receptor blocker for maintaining a persistent elevation of gastric pH after colon resection for cancer.
    Hsu TC; Su CF; Leu SC; Huang PC; Wang TE; Chu CH
    Am J Surg; 2004 Jan; 187(1):20-3. PubMed ID: 14706580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial.
    Lundell L; Havu N; Miettinen P; Myrvold HE; Wallin L; Julkunen R; Levander K; Hatlebakk JG; Liedman B; Lamm M; Malm A; Walan A;
    Aliment Pharmacol Ther; 2006 Mar; 23(5):639-47. PubMed ID: 16480403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypochlorhydria induced by a proton pump inhibitor leads to intragastric microbial production of acetaldehyde from ethanol.
    Väkeväinen S; Tillonen J; Salaspuro M; Jousimies-Somer H; Nuutinen H; Färkkilä M
    Aliment Pharmacol Ther; 2000 Nov; 14(11):1511-8. PubMed ID: 11069323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term acid suppression by omeprazole in gastro-oesophageal reflux disease patients does not lead to anti-gastric autoantibody production.
    Bergman MP; Klinkenberg-Knol EC; Faller G; Aar A; Lakhai W; Vandenbroucke-Grauls CM; Kuipers EJ; Appelmelk BJ
    Aliment Pharmacol Ther; 2005 Apr; 21(8):977-83. PubMed ID: 15813833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misoprostol and omeprazole in the prevention of chemotherapy-induced acute gastroduodenal mucosal injury. A randomized, placebo-controlled pilot study.
    Sartori S; Trevisani L; Nielsen I; Tassinari D; Abbasciano V
    Cancer; 1996 Oct; 78(7):1477-82. PubMed ID: 8839554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.